Group 1 - The core viewpoint of the news is that Baiao Chemical's stock has increased by 5.14%, reaching a price of 26.40 CNY per share, with a trading volume of 209 million CNY and a turnover rate of 1.15%, resulting in a total market capitalization of 18.644 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, sales of by-products at 0.23%, and others at 0.22% [1] Group 2 - Among Baiao Chemical's top ten circulating shareholders, a fund under Southern Fund has entered the list, specifically the Southern CSI 1000 ETF (512100), which acquired 3.2711 million shares, accounting for 0.46% of the circulating shares [2] - The Southern CSI 1000 ETF (512100) was established on September 29, 2016, with a latest scale of 64.953 billion CNY, and has achieved a year-to-date return of 25.67% [2] - The fund has a one-year return of 67.42%, ranking 1298 out of 3814 in its category, and since its inception, it has returned 11.21% [2]

Core Viewpoint - Dalian Baiao Chemical Co., Ltd. reported a revenue of 749 million yuan for the first half of 2025, marking a year-on-year increase of 28.42%, while net profit decreased by 44.22% to 91.79 million yuan [1] Group 1: Financial Performance - The company achieved a revenue of 749 million yuan, reflecting a growth of 28.42% compared to the previous year [1] - Net profit for the first half of the year was 91.79 million yuan, which represents a decline of 44.22% year-on-year [1] Group 2: Business Segments - Baiao Chemical has established a dual business model focusing on industrial biocides and semiconductor equipment [1] - The chemical business is facing challenges due to external environmental factors, weak market demand, and continuously low prices, leading to sustained pressure on profitability [1] - The semiconductor business is part of a long-term strategic plan aimed at technology accumulation and building a competitive advantage [1] Group 3: Market Trends - Despite the overall pressure on the biocide business, positive changes are emerging, with the average sales price of biocide products increasing by 7.69% quarter-on-quarter [1] - The comprehensive procurement cost of key raw materials, including n-octylamine, methyl acrylate, magnesium nitrate, ethyl acetate, and chlorine, decreased by 21.37% quarter-on-quarter [1] - The gross margin of the industrial biocide business is expected to improve on a quarter-on-quarter basis [1]

Group 1 - The core point of the news is that Baiao Chemical's stock price dropped by 5.01% to 25.58 CNY per share, with a trading volume of 494 million CNY and a turnover rate of 2.69%, resulting in a total market capitalization of 18.065 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, sales of by-products at 0.23%, and others at 0.22% [1] Group 2 - From the perspective of Baiao Chemical's top ten circulating shareholders, Southern Fund has a fund that ranks among the top shareholders, specifically the Southern CSI 1000 ETF (512100), which entered the top ten in the second quarter with 3.2711 million shares, accounting for 0.46% of circulating shares [2] - The estimated floating loss for the Southern CSI 1000 ETF today is approximately 4.416 million CNY [2] - The Southern CSI 1000 ETF was established on September 29, 2016, with a latest scale of 64.953 billion CNY, and has achieved a year-to-date return of 26.2% [2]

Core Viewpoint - Dalian Baiao Chemical Co., Ltd. has received a corrective order from the Dalian Securities Regulatory Bureau, requiring the company to rectify issues related to internal controls and compliance with regulations [1][2]. Group 1: Issues Identified - The company has identified problems in its internal controls regarding fund management, procurement management, and contract management [2][7][11]. - Specific violations include breaches of the "Guidelines for the Governance of Listed Companies" and "Internal Control Application Guidelines" [2][7][11]. Group 2: Rectification Measures - For fund management, the company has implemented strict procedures for fund payment, ensuring all payment requests undergo prior review and approval [3][4]. - The procurement process has been optimized, requiring documentation to confirm receipt of goods before payment is processed [4][8]. - The company has revised its contract management policies to ensure compliance with internal regulations and has enhanced training for relevant personnel [13][14]. Group 3: Completion and Future Actions - The company has completed the rectification measures and will continue to enforce compliance with internal control systems [6][10][15]. - There is a commitment to ongoing training for directors and senior management to ensure adherence to legal and regulatory requirements [16].

证券代码：603360 证券简称：百傲化学 公告编号：2025-073 大连百傲化学股份有限公司 关于大连证监局对公司采取责令改正措施决定的 整改报告的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 大连百傲化学股份有限公司（以下简称"公司"）于 2025 年 8 月 14 日收到 中国证券监督管理委员会大连监管局下发的《关于对大连百傲化学股份有限公司 采取责令改正措施并对刘宪武、王希梁采取出具警示函措施的决定》（行政监管 措施〔2025〕16 号）（以下简称"《决定书》"），要求公司对《决定书》中指出 的事项进行整改。具体内容详见公司于 2025 年 8 月 16 日在上海证券交易所网站 （www.sse.com.cn）披露的《大连百傲化学股份有限公司关于收到大连证监局行 政监管措施决定书的公告》（公告编号：2025-056）。 收到《决定书》后，公司高度重视，迅速组织相关部门和人员对《决定书》 中所涉及的问题进行了全面梳理，根据相关法律、法规、规范性文件以及公司内 部管理制度，并结合公司实际情况，认真进行整改。 公司 ...

Core Viewpoint - Dalian Baiao Chemical Co., Ltd. has completed the rectification measures required by the Dalian Securities Regulatory Bureau regarding internal control issues and will continue to enforce these measures for sustainable development and shareholder protection [1][3]. Summary by Category Rectification Measures - The company received a decision from the Dalian Regulatory Bureau on August 14, 2025, requiring rectification of identified issues [1]. - The fifth board meeting on September 18, 2025, approved the rectification report, detailing specific issues and measures taken [2]. Internal Control Issues 1. **Funds Management Internal Control** - **Issue**: Violated the "Corporate Governance Guidelines (2018 Revision)" and "Internal Control Application Guidelines No. 6 - Fund Activities" [2]. - **Measures**: Reviewed management systems, adhered to "Working Capital Management Methods," optimized payment processes, and trained financial staff [2]. - **Completion**: Measures have been completed and will be continuously enforced [2]. 2. **Procurement Management Internal Control** - **Issue**: Violated "Internal Control Application Guidelines No. 7 - Procurement Business" [2]. - **Measures**: Streamlined procurement processes, revised internal control systems, enhanced payment tracking, and trained procurement personnel [2]. - **Completion**: Measures have been completed and will be continuously enforced [2]. 3. **Contract Management Internal Control** - **Issue**: Violated "Internal Control Application Guidelines No. 16 - Contract Management" [2]. - **Measures**: Reviewed existing contract management systems, ensured strict execution by relevant departments, and improved contract management through information technology [2]. - **Completion**: Measures have been completed and will be continuously enforced [2]. Future Outlook - The company aims to strengthen internal control governance and promote sustainable development through the rectification process, ensuring the interests of the company and all shareholders are maintained [3].

证券代码：603360 证券简称：百傲化学 公告编号：2025-074 大连百傲化学股份有限公司 注：（1）本次股份质押涉及的被担保主债权到期日为 2026 年 3 月 15 日，质押到 期日以实际办理质押解除登记手续日为准。 （2）公司于 2025 年 5 月 23 日披露了 2024 年年度权益分派实施公告，以 2025 年 5 关于控股股东股份质押的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 大连百傲化学股份有限公司（以下简称"公司"）控股股东大连通运投 资有限公司（以下简称"通运投资"）持有公司股份总数为 211,581,520 股，占 公司总股本的 29.96%。截至本公告日，通运投资累计质押的公司股份数为 46,000,000 股，占其持有公司股份总数的 21.74%，占公司总股本的 6.51%。 一、本次股份质押情况 公司近日接到控股股东通运投资通知，通运投资为质押给烟台华周投资中心 （有限合伙）的本公司 3,000,000 股股份办理了质押登记手续，具体事项如下： | 股东名称 | 是否 ...

证券代码：603360 证券简称：百傲化学 公告编号：2025-073 关于大连证监局对公司采取责令改正措施决定的 整改报告的公告 大连百傲化学股份有限公司（以下简称"公司"）于 2025 年 8 月 14 日收到 中国证券监督管理委员会大连监管局下发的《关于对大连百傲化学股份有限公司 采取责令改正措施并对刘宪武、王希梁采取出具警示函措施的决定》（行政监管 措施〔2025〕16 号）（以下简称"《决定书》"），要求公司对《决定书》中指 出的事项进行整改。具体内容详见公司于 2025 年 8 月 16 日在上海证券交易所网 站（www.sse.com.cn）披露的《大连百傲化学股份有限公司关于收到大连证监局 行政监管措施决定书的公告》（公告编号：2025-056）。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 大连百傲化学股份有限公司 收到《决定书》后，公司高度重视，迅速组织相关部门和人员对《决定书》 中所涉及的问题进行了全面梳理，根据相关法律、法规、规范性文件以及公司内 部管理制度，并结合公司实际情况，认真进行整改。 公司 ...

Core Viewpoint - Dalian Baiao Chemical Co., Ltd. announced a pledge of shares by its controlling shareholder, Tongyun Investment, which holds 211,581,520 shares, accounting for 29.96% of the total share capital [1] Summary by Relevant Sections - **Share Pledge Details** - Tongyun Investment pledged 3,000,000 shares to Yantai Huazhou Investment Center (Limited Partnership), with the pledge starting on September 17, 2025, and the expiration date subject to the completion of deregistration procedures [1] - The pledged shares represent 1.42% of Tongyun Investment's holdings and 0.42% of the company's total share capital [1] - **Cumulative Pledge Information** - As of the announcement date, Tongyun Investment has cumulatively pledged 46,000,000 shares, which is 21.74% of its total holdings and 6.51% of the company's total share capital [1]

Group 1 - The core viewpoint of the news is that Baiao Chemical's stock has seen a significant increase of 5.31%, reaching a price of 26.20 CNY per share, with a trading volume of 236 million CNY and a turnover rate of 1.32%, resulting in a total market capitalization of 18.503 billion CNY [1] - Baiao Chemical, established on September 22, 2003, and listed on February 6, 2017, specializes in the research, production, and sales of isothiazolinone-based industrial biocides [1] - The company's main business revenue composition includes industrial biocides at 54.95%, semiconductors at 44.36%, key components and consumables at 0.23%, sales of by-products at 0.23%, and others at 0.22% [1] Group 2 - Southern Fund's Southern CSI 1000 ETF (512100) has entered the top ten circulating shareholders of Baiao Chemical, holding 3.2711 million shares, which accounts for 0.46% of the circulating shares, with an estimated floating profit of approximately 4.3178 million CNY [2] - The Southern CSI 1000 ETF was established on September 29, 2016, with a latest scale of 64.953 billion CNY, achieving a year-to-date return of 28.17% and a one-year return of 72.87% [2] - The fund manager of Southern CSI 1000 ETF is Cui Lei, who has been in the position for 6 years and 317 days, with a total fund asset scale of 94.976 billion CNY and a best fund return of 142.69% during the tenure [3]